Related Experiment Video
Updated: Aug 11, 2026
13:45
Merkel Cell Polyomavirus Infection and Detection
Published on: February 7, 2019
[Merkel cell carcinoma. Study of five cases]
Josep Bertó1, Asunción Cuenca, Beatriz Díaz-Martínez
1Servicio de Dermatología, Hospital Clínico San Carlos, Doctor Martín Lagos s/n, 28040 Madrid, Spain. josepberto@yahoo.es
Actas Dermo-Sifiliograficas
|February 16, 2006
Summary
Merkel cell carcinoma (MCC), a rare and aggressive skin cancer, requires prompt diagnosis and treatment. Early detection and aggressive management are crucial for improving patient survival rates due to high recurrence.
Area of Science:
- Oncology
- Dermatopathology
- Neurosurgery
Context:
- Merkel cell carcinoma (MCC) is a rare, aggressive neuroendocrine skin cancer.
- It often presents as an erythematous nodule, frequently on the face.
- Histologically, MCC features small cells with specific markers like cytokeratins AE1/AE3.
Purpose:
- To report on five cases of Merkel cell carcinoma treated at a single institution.
- To highlight key clinical, histological, and prognostic features of MCC.
- To emphasize the importance of early diagnosis and aggressive management.
Summary:
- Five patients with Merkel cell carcinoma (MCC) were analyzed over three years.
- The study observed typical presentations, histological findings, and treatment responses.
- Key features include rapid progression, neuroendocrine markers, and high recurrence rates.
Impact:
- Highlights the need for including MCC in differential diagnoses for suspicious skin lesions.
- Underscores that early detection and aggressive treatment significantly improve survival.
- Suggests the need for a standardized response protocol for better disease management.
